PURPOSE: To investigate the frequency of xenotropic murine leukemia virus (MLV) presence in human cell lines established from mouse xenografts and to search for the evidence of horizontal viral spread to other cell lines. RESULTS: Six of 23 (26%) mouse DNA free xenograft cultures were strongly positive for MLV and their sequences had greater than 99% homology to known MLV strains. Four of five available supernatant fluids from these viral positive cultures were strongly positive for RT activity. Three of these supernatant fluids were studied to confirm the infectivity of the released virions for other human culture cells. Of the 78 non-xenograft derived cell lines maintained in the xenograft culture-containing facilities, 13 (17%) were positive for MLV, including XMRV, a virus strain first identified in human tissues. By contrast, all 50 cultures maintained in a xenograft culture-free facility were negative for viral sequences. METHODOLOGY: We examined xenograft tumor cell lines from seven independent laboratories and 128 non-xenografted tumor cell lines. Cell line DNA was examined for mouse DNA contamination, and by 3 Taqman qPCR assays targeting the gag, env or pol regions of MLV. Sequencing was used for viral strain identification. Supernatant fluids were tested for reverse transcriptase (RT) activity. CONCLUSIONS: Human cultures derived after mouse xenografting frequently contain and release highly infectious xenotropic MLV viruses. Laboratories working with xenograft-derived human cultures should be aware of the risk of contamination with potentially biohazardous human-tropic mouse viruses and their horizontal spread to other cultures.
PURPOSE: To investigate the frequency of xenotropic murine leukemia virus (MLV) presence in human cell lines established from mouse xenografts and to search for the evidence of horizontal viral spread to other cell lines. RESULTS: Six of 23 (26%) mouse DNA free xenograft cultures were strongly positive for MLV and their sequences had greater than 99% homology to known MLV strains. Four of five available supernatant fluids from these viral positive cultures were strongly positive for RT activity. Three of these supernatant fluids were studied to confirm the infectivity of the released virions for other human culture cells. Of the 78 non-xenograft derived cell lines maintained in the xenograft culture-containing facilities, 13 (17%) were positive for MLV, including XMRV, a virus strain first identified in human tissues. By contrast, all 50 cultures maintained in a xenograft culture-free facility were negative for viral sequences. METHODOLOGY: We examined xenograft tumor cell lines from seven independent laboratories and 128 non-xenografted tumor cell lines. Cell line DNA was examined for mouse DNA contamination, and by 3 Taqman qPCR assays targeting the gag, env or pol regions of MLV. Sequencing was used for viral strain identification. Supernatant fluids were tested for reverse transcriptase (RT) activity. CONCLUSIONS: Human cultures derived after mouse xenografting frequently contain and release highly infectious xenotropic MLV viruses. Laboratories working with xenograft-derived human cultures should be aware of the risk of contamination with potentially biohazardous human-tropic mouse viruses and their horizontal spread to other cultures.
Authors: Kirby L Johnson; Kimberly A Dukes; John Vidaver; Erik S LeShane; Idania Ramirez; William D Weber; Farideh Z Bischoff; Sinuhe Hahn; Arun Sharma; Dianne X Dang; Lisa M Hire; Diana W Bianchi; Joe Leigh Simpson; Wolfgang Holzgreve; Sherman Elias; Katherine W Klinger Journal: Clin Chem Date: 2004-01-12 Impact factor: 8.327
Authors: P Lusso; F di Marzo Veronese; B Ensoli; G Franchini; C Jemma; S E DeRocco; V S Kalyanaraman; R C Gallo Journal: Science Date: 1990-02-16 Impact factor: 47.728
Authors: Mark J Robinson; Otto W Erlwein; Steve Kaye; Jonathan Weber; Oya Cingoz; Anup Patel; Marjorie M Walker; Wun-Jae Kim; Mongkol Uiprasertkul; John M Coffin; Myra O McClure Journal: Retrovirology Date: 2010-12-20 Impact factor: 4.602
Authors: Otto Erlwein; Steve Kaye; Myra O McClure; Jonathan Weber; Gillian Wills; David Collier; Simon Wessely; Anthony Cleare Journal: PLoS One Date: 2010-01-06 Impact factor: 3.240
Authors: Jeannette S Kirkegaard; Philippe Ravassard; Signe Ingvarsen; Marc Diedisheim; Emilie Bricout-Neveu; Mads Grønborg; Thomas Frogne; Raphael Scharfmann; Ole D Madsen; Claude Rescan; Olivier Albagli Journal: J Clin Invest Date: 2016-02-22 Impact factor: 14.808
Authors: Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch Journal: Science Date: 2011-09-22 Impact factor: 47.728
Authors: Devinka Bamunusinghe; Qingping Liu; Ronald Plishka; Michael A Dolan; Matthew Skorski; Andrew J Oler; Venkat R K Yedavalli; Alicia Buckler-White; Janet W Hartley; Christine A Kozak Journal: J Virol Date: 2017-10-13 Impact factor: 5.103